Latest VR Adviser, LLC Stock Portfolio
VR Adviser, LLC Performance:
2024 Q3: 7.01%YTD: 16.95%2023: 5.35%
Performance for 2024 Q3 is 7.01%, and YTD is 16.95%, and 2023 is 5.35%.
About VR Adviser, LLC and 13F Hedge Fund Stock Holdings
VR Adviser, LLC is a hedge fund based in NEW YORK, NY. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.4 Billions. In it's latest 13F Holdings report, VR Adviser, LLC reported an equity portfolio of $1.9 Billions as of 30 Sep, 2024.
The top stock holdings of VR Adviser, LLC are , OCUL, . The fund has invested 26.1% of it's portfolio in APOGEE THERAPEUTICS INC and 5.8% of portfolio in OCULAR THERAPEUTIX INC.
The fund managers got completely rid off ARCA BIOPHARMA INC (ABIO) stocks. They significantly reduced their stock positions in ZURA BIO LTD, EDGEWISE THERAPEUTICS INC (EWTX) and MERUS N V (MRUS). VR Adviser, LLC opened new stock positions in ORUKA THERAPEUTICS INC, INSTIL BIO INC (TIL) and TENAX THERAPEUTICS INC (TENX). The fund showed a lot of confidence in some stocks as they added substantially to CASI PHARMACEUTICALS INC, APPLIED THERAPEUTICS INC (APLT) and TREVI THERAPEUTICS INC (TRVI).
The top stock holdings of VR Adviser, LLC are , OCUL, . The fund has invested 26.1% of it's portfolio in APOGEE THERAPEUTICS INC and 5.8% of portfolio in OCULAR THERAPEUTIX INC.
The fund managers got completely rid off ARCA BIOPHARMA INC (ABIO) stocks. They significantly reduced their stock positions in ZURA BIO LTD, EDGEWISE THERAPEUTICS INC (EWTX) and MERUS N V (MRUS). VR Adviser, LLC opened new stock positions in ORUKA THERAPEUTICS INC, INSTIL BIO INC (TIL) and TENAX THERAPEUTICS INC (TENX). The fund showed a lot of confidence in some stocks as they added substantially to CASI PHARMACEUTICALS INC, APPLIED THERAPEUTICS INC (APLT) and TREVI THERAPEUTICS INC (TRVI).
VR Adviser, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that VR Adviser, LLC made a return of 7.01% in the last quarter. In trailing 12 months, it's portfolio return was 38.8%.
New Buys
| Ticker | $ Bought |
|---|---|
| oruka therapeutics inc | 75,628,500 |
| artiva biotherapeutics inc | 24,867,800 |
| instil bio inc | 2,233,480 |
| tenax therapeutics inc | 720,832 |
New stocks bought by VR Adviser, LLC
Additions
| Ticker | % Inc. |
|---|---|
| casi pharmaceuticals inc | 783 |
| engene holdings inc | 26.18 |
| applied therapeutics inc | 2.96 |
| trevi therapeutics inc | 0.00 |
| viridian therapeutics inc | 0.00 |
Additions to existing portfolio by VR Adviser, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| zura bio ltd | -66.41 |
| edgewise therapeutics inc | -45.00 |
| merus n v | -28.12 |
| arvinas inc | -27.61 |
| dianthus therapeutics inc | -16.71 |
| astria therapeutics inc | -4.16 |
VR Adviser, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| arca biopharma inc | -3,318,220 |
VR Adviser, LLC got rid off the above stocks
Sector Distribution
VR Adviser, LLC has about 54.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 54.2 |
| Others | 45.8 |
Market Cap. Distribution
VR Adviser, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 45.8 |
| SMALL-CAP | 44.7 |
| MID-CAP | 6.5 |
| MICRO-CAP | 3 |
Stocks belong to which Index?
About 38.1% of the stocks held by VR Adviser, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 61.9 |
| RUSSELL 2000 | 38.1 |
VR Adviser, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of VR Adviser, LLC
VR Adviser, LLC has 38 stocks in it's portfolio. About 65.6% of the portfolio is in top 10 stocks. FDMT proved to be the most loss making stock for the portfolio. VRDN was the most profitable stock for VR Adviser, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABIO | arca biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADVM | adverum biotechnologies inc | 0.54 | 1,467,050 | 10,298,700 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 4.14 | 2,685,450 | 78,979,000 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 4.37 | 9,825,000 | 83,512,500 | added | 2.96 | ||
| AQST | aquestive therapeutics inc | 1.45 | 5,555,560 | 27,666,700 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.59 | 454,450 | 11,193,100 | reduced | -27.61 | ||
| ATXS | astria therapeutics inc | 1.99 | 3,458,640 | 38,079,700 | reduced | -4.16 | ||
| CABA | cabaletta bio inc | 0.39 | 1,563,950 | 7,381,850 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics inc | 1.21 | 1,379,960 | 23,100,600 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 3.21 | 5,684,170 | 61,389,000 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 4.09 | 2,173,910 | 78,087,000 | unchanged | 0.00 | ||
| ERAS | erasca inc | 2.32 | 16,216,200 | 44,270,300 | unchanged | 0.00 | ||
| EWTX | edgewise therapeutics inc | 1.40 | 1,000,000 | 26,690,000 | reduced | -45.00 | ||
| FDMT | 4d molecular therapeutics in | 2.49 | 4,400,000 | 47,564,000 | unchanged | 0.00 | ||
| IPSC | century therapeutics inc | 0.48 | 5,389,260 | 9,215,630 | unchanged | 0.00 | ||
| KALV | kalvista pharmaceuticals inc | 3.79 | 6,249,730 | 72,371,900 | unchanged | 0.00 | ||
| MRSN | mersana therapeutics inc | 1.12 | 11,328,000 | 21,409,900 | unchanged | 0.00 | ||
| MRUS | merus n v | 2.38 | 907,963 | 45,361,800 | reduced | -28.12 | ||
| OCUL | ocular therapeutix inc | 5.82 | 12,762,500 | 111,033,000 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals inc | 2.36 | 4,394,530 | 45,043,900 | unchanged | 0.00 | ||